TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ADCT

ADC Therapeutics SA

Healthcare · Biotechnology

1.10$ -0.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

ADC Therapeutics SA (ADCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -141 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ADCT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-75 -121 -122 -169 -233 -137 -119 -124 -141
0.3 0.7 1.6 2.2 2.6 2.3 3.3 3.3 1.9
1.0 0.5 1.1 38 60 49 13 6.6 6.9
1.1 -0.2 1.0 63 14 50
14 0.5 -7.9 12 -16 -33 44 3.8 -25
3.2 2.5 2.1 2.8 6.4 0.6 3.2 0.9 0.3
-3.2 -2.5 -2.2 -2.8 -6.7 -2.5 -3.2 -0.9 0.4
197 0.0 -0.1 0.0 0.0 -0.2
-1.0 -1.0 -1.0 62 49 -6.5 0.0
197 0.0 101 495 267 -0.6 74 97 151
119 -124 -23 324 27 -140 -48 -28 10
-78 -124 -124 -172 -240 -137 -122 -125 -141

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?